Prasteron-Enantat ist ein synthetischer Wirkstoff, gespritzt, langlebiges Ester-Prodrug von Dehydroepiandrosteron (DHEA), ein schwaches Androgen und Neurosteroid. Es ist Bestandteil von Gynodian Depot, eine Kombinationsformulierung von 4 mg Östradiolvalerat und 200 mg Prasteron-Enantat in Öl zur intramuskulären Depot-Injektion, typischerweise einmal alle 4 Wochen, that is used in the treatment of menopausal symptoms and is marketed in Europe and South America. Prasterone enanthate has an average duration of 18 days in this formulation. The pharmacokinetics of the formulation have also been assessed in other studies. The medication was patented, by Schering, in 1971.
1. Retard aging and maintain youthful vigor
2. Enhance physical fitness, improve mood and sleep, improve memory
3. Improve sexual function, increase libido
4. Regulate the immune system function, improve the body immunity
5 weight loss
6 auxiliary treatment of diseases
